NCT06671886Recruiting
NAFLD Clinical Care Pathway
Testing the Effectiveness of NAFLD Clinical Care Pathway in VA Primary Care
Source: ClinicalTrials.gov · Last updated 5 Nov 2026
Brief summary (registry, in English)
Non-alcoholic fatty liver disease (NAFLD) is a new condition that has become the most common chronic liver disease in the world and a main cause of liver cirrhosis, liver failure and liver cancer. Obesity and diabetes, conditions that are very common among Veterans are the main risk factors for NAFLD. Therefore, the burden of NAFLD and its complications among Veterans is substantial. However, most VA patients with NAFLD are undiagnosed and untreated, and their care is not consistent with practice guidelines. The NAFLD Clinical Care Pathway (NCCP) intervention seeks to close this major gap in the care of Veterans by automatically identifying patients at risk of NAFLD, calculating their risk scores of having severe NAFLD, and educating the primary care providers on the diagnosis and treatment of NAFLD. This clinical trial will test the benefit of this NCCP intervention against usual care in increasing the rates of NAFLD diagnosis as well as referral to and enrollment in appropriate treatment. The study will also identify barriers and promotors of future NCCP implementation.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- First submitted
- 30 Oct 2024
- Start date
- 2 Feb 2024
- Primary completion date
- 31 Jan 2028
- Lead sponsor
- VA Office of Research and Development
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT06671886
What you commit to
- Study type: Interventional
- Planned participants: 32
- From 2 Feb 2024 to the primary completion date, 31 Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- The investigators will exclude PACTs with unstable leadership (i.e., pending departure, vacancy) at time of randomization
- PACTs participating in the focus groups in Aim 1 will be excluded in Aim 2 to avoid cross contamination
- PACTs meeting the following criteria will be excluded from randomization in Aim 2:
- PACTs who do not treat NAFLD
- PACTs not located at the main hospital
- PACTs with less than 100 visits within 3 months
Who the study is looking for
- Patient Aligned Care Teams (PACT) at the Michael E. DeBakey VA Medical Center
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Michael E. DeBakey VA Medical Center, Houston, TX Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.